These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 27798337)

  • 1. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial.
    Goehring KC; Marriage BJ; Oliver JS; Wilder JA; Barrett EG; Buck RH
    J Nutr; 2016 Dec; 146(12):2559-2566. PubMed ID: 27798337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infants Fed Breastmilk or 2'-FL Supplemented Formula Have Similar Systemic Levels of Microbiota-Derived Secondary Bile Acids.
    Hill DR; Buck RH
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prebiotic effect of an infant formula supplemented with galacto-oligosaccharides: randomized multicenter trial.
    Giovannini M; Verduci E; Gregori D; Ballali S; Soldi S; Ghisleni D; Riva E;
    J Am Coll Nutr; 2014; 33(5):385-93. PubMed ID: 25302927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.
    Autran CA; Schoterman MH; Jantscher-Krenn E; Kamerling JP; Bode L
    Br J Nutr; 2016 Jul; 116(2):294-9. PubMed ID: 27212112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2'-Fucosyllactose.
    Reverri EJ; Devitt AA; Kajzer JA; Baggs GE; Borschel MW
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30241407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial.
    Nowacki J; Lee HC; Lien R; Cheng SW; Li ST; Yao M; Northington R; Jan I; Mutungi G
    Nutr J; 2014 Nov; 13():105. PubMed ID: 25373935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world study in infants fed with an infant formula with two human milk oligosaccharides.
    Román E; Moreno Villares JM; Domínguez Ortega F; Carmona Martínez A; Picó Sirvent L; Santana Sandoval L; Casas Rivero J; Alshweki A; Cercamondi C; Dahbane S; Vidal Guevara ML
    Nutr Hosp; 2020 Aug; 37(4):698-706. PubMed ID: 32698596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Partly Fermented Infant Formula with Postbiotics Including 3'-GL, Specific Oligosaccharides, 2'-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial.
    Vandenplas Y; de Halleux V; Arciszewska M; Lach P; Pokhylko V; Klymenko V; Schoen S; Abrahamse-Berkeveld M; Mulder KA; Porcel Rubio R; On Behalf Of The Voyage Study Group
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33233658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial.
    Ashley C; Johnston WH; Harris CL; Stolz SI; Wampler JL; Berseth CL
    Nutr J; 2012 Jun; 11():38. PubMed ID: 22676715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants.
    Marriage BJ; Buck RH; Goehring KC; Oliver JS; Williams JA
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):649-58. PubMed ID: 26154029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
    Berger B; Porta N; Foata F; Grathwohl D; Delley M; Moine D; Charpagne A; Siegwald L; Descombes P; Alliet P; Puccio G; Steenhout P; Mercenier A; Sprenger N
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
    Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
    BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels.
    Alliet P; Scholtens P; Raes M; Hensen K; Jongen H; Rummens JL; Boehm G; Vandenplas Y
    Nutrition; 2007 Oct; 23(10):719-23. PubMed ID: 17664059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial.
    Johnston WH; Ashley C; Yeiser M; Harris CL; Stolz SI; Wampler JL; Wittke A; Cooper TR
    BMC Pediatr; 2015 Nov; 15():173. PubMed ID: 26547414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a whey-predominant starter formula containing LCPUFAs and oligosaccharides (FOS/GOS) on gastrointestinal comfort in infants.
    Vivatvakin B; Mahayosnond A; Theamboonlers A; Steenhout PG; Conus NJ
    Asia Pac J Clin Nutr; 2010; 19(4):473-80. PubMed ID: 21147707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth.
    Parschat K; Melsaether C; Jäpelt KR; Jennewein S
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial.
    Holscher HD; Faust KL; Czerkies LA; Litov R; Ziegler EE; Lessin H; Hatch T; Sun S; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):95S-105S. PubMed ID: 22237884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial.
    Closa-Monasterolo R; Gispert-Llaurado M; Luque V; Ferre N; Rubio-Torrents C; Zaragoza-Jordana M; Escribano J
    Clin Nutr; 2013 Dec; 32(6):918-27. PubMed ID: 23498848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial.
    Alliet P; Vandenplas Y; Roggero P; Jespers SNJ; Peeters S; Stalens JP; Kortman GAM; Amico M; Berger B; Sprenger N; Cercamondi CI; Corsello G
    Nutr J; 2022 Feb; 21(1):11. PubMed ID: 35193609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth, Nutrition, and Cytokine Response of Breast-fed Infants and Infants Fed Formula With Added Bovine Osteopontin.
    Lönnerdal B; Kvistgaard AS; Peerson JM; Donovan SM; Peng YM
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):650-7. PubMed ID: 26465791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.